Biomarkers Market Size, Share, Opportunity and Global Report 2024-2031

Biomarkers Market Size, Share, Industry, Forecast (2024-2031)

<h2>Global Biomarkers Market is segmented By Product Type (Diagnostic Biomarkers, Monitoring Biomarkers, Predictive Biomarkers, Susceptibility/Risk Biomarkers, Prognostic Biomarkers, Pharmacodynamic/Response Biomarkers, Safety Biomarkers, Others)&nbsp;By Application (Drug Discovery and Development, Disease Diagnostics, Disease Risk Assessment, Personalized Medicine, Others) By End-User (Pharmaceutical Companies, Biotechnology Companies, Research Centers and Institutes, Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

&nbsp;

<h3>Biomarkers Market Size</h3>

<blockquote>
The Global Biomarkers Market reached US$ YY&nbsp;million in 2022 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Biomarkers also known as biological markers, is a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention. Biomarkers are used for the diagnosis health status of an individual. In medical terms, a measurable biomarker is a chemical component that reflects the presence as well as the severity of the disease.

Moreover, biomarkers are the measures used to perform a clinical assessment such as blood pressure or cholesterol level and are used to monitor and predict health states in individuals or across populations so that appropriate therapeutic intervention can be planned. Biomarkers may be used alone or in combination to assess the health or disease state of an individual. Every biological system has its own specific biomarkers. Many of these biomarkers are relatively easy to measure and form part of routine medical examinations.

&nbsp;

<h3>Biomarkers Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size&nbsp;
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product Type, Application and End-User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For More Insights&nbsp;<a href="https://www.datamintelligence.com/download-sample/biomarkers-market" target="_blank">Request free Sample</a>

&nbsp;

<h3>Biomarkers Market: Drivers</h3>

Increasing novel approaches and increasing adoption in the diagnosis of cancer

The increasing novel approaches and increasing adoption of biomarker in cancer cases is expected to drive the market over the forecast period. The biomarkers are most commonly used in the detection of cancer, especially ovarian cancer. The increasing prevalence of ovarian cancer leads to the increasing adoption of the biomarkers. For instance, according to Global Cancer Statistics, 2020, Ovarian cancer is the seventh most frequent cancer in women worldwide, accounting for around 314,000 new cases (3.4% of all new cancer cases in females) per year.&nbsp;

Moreover, cancer Antigen-125 (CA-125) and transvaginal imaging are commonly used to diagnose ovarian cancer. The most commonly used serum biomarker is CA-125, although it lacks the sensitivity and specificity to be utilized alone as a screening test. It is also ineffective for early diagnosis since CA-125 expression levels are too low for accurate detection.&nbsp;

For instance, on November 07, 2022, Akoya Biosciences, Inc. launched the PhenoCode Signature Panels for high-throughput spatial biomarker discovery and validation on the PhenoImager platforms. Each of the customizable multiplex panels includes key markers for phenotyping the tumor microenvironment (TME) and immune status. When combined with the high-speed and robust imaging of the PhenoImager platforms, a rapid, quantitative, end-to-end spatial phenotyping workflow is enabled. The workflow accelerates the development and validation of predictive signatures and prognostic biomarkers for immuno-oncology applications.

Additionally, many novel approaches are going on in the field of biomarkers. For instance, on April 19, 2021, Amgen launched the Biomarker Assist to help more patients with metastatic (stage IV) non-small cell lung cancer (NSCLC) gain access to biomarker testing. Biomarker testing at the time of diagnosis is a critical first step in getting patients on the right treatment. Through Biomarker Assist, eligible patients may save on biomarker testing.&nbsp;

The technological advancements in biomarkers increase the adoption of biomarkers. For instance, on January 11, 2021, Biogen Inc. released a new virtual research study, in collaboration with Apple, to investigate the role Apple Watch and iPhone could play in monitoring cognitive performance and screening for decline in cognitive health including mild cognitive impairment (MCI). The study&rsquo;s primary objectives are to develop digital biomarkers to help monitor cognitive performance over time and identify early signs of MCI.

Further, the increasing prevalence of cancers, rising FDA approvals, increasing clinical trials, increasing awareness and technological advancements are the factors expected to drive the market over the forecast period.

<h3>Restraints</h3>

Factors such as complications associated with the biomarkers, high investment costs, problems such as sample storage and collection, and unfavorable reimbursement scenarios are expected to hamper the market growth during the forecast period.

<h3>Biomarkers Market Segment Analysis</h3>

The global biomarkers market is segmented based on product type, application, end-user and region.

The diagnostic biomarkers segment accounted for approximately 43.2% of the biomarkers market share

The diagnostic biomarkers segment is expected to hold the largest market share over the forecast period. The diagnostic biomarkers play a crucial role in the disease diagnosis. Diagnostic biomarkers may be used not only to identify people with a disease but also to redefine the classification of the disease. Diagnostic biomarkers identify disease subtypes and thus often play critical roles when the results of diagnostic classification can be used as prognostic biomarkers and predictive biomarkers.

For instance, on July 13, 2023, Quest Diagnostics, the leading provider of diagnostic information services, launched a novel prostate cancer biomarker test through its subspecialty pathology business, AmeriPath, in collaboration with&nbsp; Envision Sciences. Envision Sciences Pty Ltd. is an Australian-based clinical diagnostics company developing a pipeline of biomarker-based cancer diagnostic and prognostic tests in tissue and blood.

In addition on September 08, 2023, Ibex Medical Analytics launched Galen Breast HER2, a novel breast cancer AI-powered biomarker scoring solution developed in collaboration with AstraZeneca and Daiichi Sankyo, to support improved patient outcomes. Galen Breast HER2 allows clinicians to rapidly and accurately identify patients with HER2-low who would benefit from targeted therapies.

<h3>Biomarkers Market Geographical Share</h3>

North America accounted for approximately 39.2% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption. North America especially the United States is known for its strong presence of major players such as pharmaceutical companies and biotechnology companies. The presence of major players actively adopting the biomarkers drug discovery and development of personalized medicines.

Moreover, the increasing prevalence of cancer in the region leads to the increasing adoption of biomarkers. For instance, according to the American Cancer Society, in 2020, an estimated 1.8 million new cancer cases and 606,520 cancer deaths in the United States will be diagnosed. In contrast, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Therefore, it has increased the adoption of biomarkers for cancer.

<h3>Biomarkers Companies</h3>

The major global players in the biomarkers market include Bio-Rad Laboratories Inc., Merck KGaA, QIAGEN N.V., Siemens Healthcare Private Limited, Enzo Biochem Inc., PerkinElmer Inc., BRUKER CORPORATION, Epigenomics AG, Signosis, Inc. and Thermo Fisher Scientific Inc. among others.&nbsp;

<h3>Key Developments</h3>

<ul>
	<li>On May 17, 2023, Chordia Therapeutics, Inc. released the beginning of field trials leveraging Fujitsu&rsquo;s AI causal discovery technology to shed light on biomarkers that increase the probability of success or shorten the duration of clinical trials in the development of new cancer drugs.&nbsp;</li>
	<li>On October 25, 2022, Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, launched its clinical pipeline featuring biomarkers across neuroscience, oncology, respiratory, and other therapeutic areas. With 15 digital biomarker programs in development, the company will also be launching several upcoming clinical studies.</li>
</ul>

<h3>COVID-19 Impact Analysis</h3>

The COVID-19 pandemic significantly impacted the global biomarkers market. The pandemic led to disruptions in ongoing clinical trials, delays in the initiation of new trials, and difficulties in patient recruitment. This impacted the development and validation of biomarkers.&nbsp;

With the focus on understanding and combating COVID-19, there may have been a shift in research priorities and funding away from other areas, including biomarker research for different diseases. Moreover, the pandemic likely influenced the development and use of biomarkers for diagnosing COVID-19 and monitoring its severity.&nbsp;

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global biomarkers market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development</li>
	<li>Excel data sheet with numerous data points of biomarkers market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global biomarkers market report would provide approximately 61 tables, 65 figures, and 187 Pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product Type</li>
		<li>Snippet by Application</li>
		<li>Snippet by End-User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing Novel Approaches and Increasing Adoption in the Diagnosis of Cancer</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>High Investment Costs</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Pipeline Analysis</li>
		<li>Unmet Needs</li>
		<li>Patent Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During the Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Attractiveness Index, By Product Type</li>
		</ol>
		</li>
		<li>Diagnostic Biomarkers*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Monitoring Biomarkers</li>
		<li>Predictive Biomarkers</li>
		<li>Susceptibility/Risk Biomarkers</li>
		<li>Prognostic Biomarkers</li>
		<li>Pharmacodynamic/Response Biomarkers</li>
		<li>Safety Biomarkers</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Drug Discovery and Development*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Disease Diagnostics</li>
		<li>Disease Risk Assessment</li>
		<li>Personalized Medicine</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End-User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Attractiveness Index, By End-User</li>
		</ol>
		</li>
		<li>Pharmaceutical Companies*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Biotechnology Companies</li>
		<li>Research Centers and Institutes</li>
		<li>Others&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Bio-Rad Laboratories Inc.*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Merck KGaA</li>
		<li>QIAGEN N.V.</li>
		<li>Siemens Healthcare Private Limited</li>
		<li>Enzo Biochem Inc.</li>
		<li>PerkinElmer Inc.</li>
		<li>BRUKER CORPORATION</li>
		<li>Epigenomics AG</li>
		<li>Signosis, Inc.</li>
		<li>Thermo Fisher Scientific Inc.&nbsp;&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Biomarkers Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Biomarkers Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Biomarkers Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Biomarkers Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Biomarkers Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Biomarkers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 7 Global Biomarkers Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 8 Global Biomarkers Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Biomarkers Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 10 Global Biomarkers Market Value, By End-User, 2022-2031 (US$ Million)

Table 11 Global Biomarkers Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 12 Global Biomarkers Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Biomarkers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 14 North America Biomarkers Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Biomarkers Market Value, By End-User, 2022-2031 (US$ Million)

Table 16 North America Biomarkers Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Biomarkers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 18 South America Biomarkers Market Value, By Application, 2022-2031 (US$ Million)

Table 19 South America Biomarkers Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 South America Biomarkers Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Biomarkers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Europe Biomarkers Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Biomarkers Market Value, By End-User, 2022-2031 (US$ Million)

Table 24 Europe Biomarkers Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Biomarkers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Biomarkers Market Value, By Application, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Biomarkers Market Value, By End-User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Biomarkers Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East &amp; Africa Biomarkers Market Value, By Product Type, 2022-2031 (US$ Million)

Table 30 Middle East &amp; Africa Biomarkers Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East &amp; Africa Biomarkers Market Value, By End-User, 2022-2031 (US$ Million)

Table 32 Bio-Rad Laboratories Inc.: Overview

Table 33 Bio-Rad Laboratories Inc.: Product Portfolio

Table 34 Bio-Rad Laboratories Inc.: Key Developments

Table 35 Merck KGaA: Overview

Table 36 Merck KGaA: Product Portfolio

Table 37 Merck KGaA: Key Developments

Table 38 QIAGEN N.V.: Overview

Table 39 QIAGEN N.V.: Product Portfolio

Table 40 QIAGEN N.V.: Key Developments

Table 41 Siemens Healthcare Private Limited: Overview

Table 42 Siemens Healthcare Private Limited: Product Portfolio

Table 43 Siemens Healthcare Private Limited: Key Developments

Table 44 Enzo Biochem Inc.: Overview

Table 45 Enzo Biochem Inc.: Product Portfolio

Table 46 Enzo Biochem Inc.: Key Developments

Table 47 PerkinElmer Inc.: Overview

Table 48 PerkinElmer Inc.: Product Portfolio

Table 49 PerkinElmer Inc.: Key Developments

Table 50 BRUKER CORPORATION: Overview

Table 51 BRUKER CORPORATION: Product Portfolio

Table 52 BRUKER CORPORATION: Key Developments

Table 53 Epigenomics AG: Overview

Table 54 Epigenomics AG: Product Portfolio

Table 55 Epigenomics AG: Key Developments

Table 56 Signosis, Inc.: Overview

Table 57 Signosis, Inc.: Product Portfolio

Table 58 Signosis, Inc.: Key Developments

Table 59 Thermo Fisher Scientific Inc.: Overview

Table 60 Thermo Fisher Scientific Inc.: Product Portfolio

Table 61 Thermo Fisher Scientific Inc.: Key Developments&nbsp;

List of Figures

Figure 1 Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 2 Global Biomarkers Market Share, By Product Type, 2022 &amp; 2031 (%)

Figure 3 Global Biomarkers Market Share, By Application, 2022 &amp; 2031 (%)

Figure 4 Global Biomarkers Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 5 Global Biomarkers Market Share, By Region, 2022 &amp; 2031 (%)

Figure 6 Global Biomarkers Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 7 Diagnostic Biomarkers Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 8 Monitoring Biomarkers Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 9 Predictive Biomarkers Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 10 Susceptibility/Risk Biomarkers Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 11 Prognostic Biomarkers Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 12 Pharmacodynamic/Response Biomarkers Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 13 Safety Biomarkers Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 14 Others Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 15 Global Biomarkers Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 16 Drug Discovery and Development Application in Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 17 Disease Diagnostics Application in Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 18 Disease Risk Assessment Application in Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 19 Personalized Medicine Application in Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 20 Others Application in Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 21 Global Biomarkers Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 22 Pharmaceutical Companies End-User in Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 23 Biotechnology Companies End-User in Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 24 Research Centers and Institutes End-User in Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 25 Others End-User in Global Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 26 Global Biomarkers Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 27 North America Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 28 Asia-Pacific Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 29 Europe Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 30 South America Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 31 Middle East and Africa Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 32 North America Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 33 North America Biomarkers Market Share, By Product Type, 2022 &amp; 2031 (%)

Figure 34 North America Biomarkers Market Share, By Application, 2022 &amp; 2031 (%)

Figure 35 North America Biomarkers Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 36 North America Biomarkers Market Share, By Country, 2022 &amp; 2031 (%)

Figure 37 South America Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 38 South America Biomarkers Market Share, By Product Type, 2022 &amp; 2031 (%)

Figure 39 South America Biomarkers Market Share, By Application, 2022 &amp; 2031 (%)

Figure 40 South America Biomarkers Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 41 South America Biomarkers Market Share, By Country, 2022 &amp; 2031 (%)

Figure 42 Europe Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 43 Europe Biomarkers Market Share, By Product Type, 2022 &amp; 2031 (%)

Figure 44 Europe Biomarkers Market Share, By Application, 2022 &amp; 2031 (%)

Figure 45 Europe Biomarkers Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 46 Europe Biomarkers Market Share, By Country, 2022 &amp; 2031 (%)

Figure 47 Asia-Pacific Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 48 Asia-Pacific Biomarkers Market Share, By Product Type, 2022 &amp; 2031 (%)

Figure 49 Asia-Pacific Biomarkers Market Share, By Application, 2022 &amp; 2031 (%)

Figure 50 Asia-Pacific Biomarkers Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 51 Asia-Pacific Biomarkers Market Share, By Country, 2022 &amp; 2031 (%)

Figure 52 Middle East &amp; Africa Biomarkers Market Value, 2022-2031 (US$ Million)

Figure 53 Middle East &amp; Africa Biomarkers Market Share, By Product Type, 2022 &amp; 2031 (%)

Figure 54 Middle East &amp; Africa Biomarkers Market Share, By Application, 2022 &amp; 2031 (%)

Figure 55 Middle East &amp; Africa Biomarkers Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 56 Bio-Rad Laboratories Inc.: Financials

Figure 57 Merck KGaA: Financials

Figure 58 QIAGEN N.V.: Financials

Figure 59 Siemens Healthcare Private Limited: Financials

Figure 60 Enzo Biochem Inc.: Financials

Figure 61 PerkinElmer Inc.: Financials

Figure 62 BRUKER CORPORATION: Financials

Figure 63 Epigenomics AG: Financials

Figure 64 Signosis, Inc.: Financials

Figure 65 Thermo Fisher Scientific Inc.: Financials

Biomarkers Market Size, Share, Industry, Forecast (2024-2031)

Renal Biomarkers Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 June 06

Starting from

Cancer Biomarkers Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 01

Starting from

Cardiac Biomarkers Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 March 23

Starting from

Genomic Biomarker Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 May 24

Starting from

Prostate Cancer Biomarker Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 06

Starting from

Central Nervous System (CNS) Biomarkers Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 06

Starting from